Breaking Through the Noise: Building Marketable AI Platforms in Biotech Dan Hennings Breaking Through the Noise: Building Marketable AI Platforms in Biotech Read More »
Tolerate This! The Nobel Prize Momentum Behind Autoimmune Disease Treatments Dan Hennings Tolerate This! The Nobel Prize Momentum Behind Autoimmune Disease Treatments Read More »
The Future of Oncology Trials: Aligning Science, Regulation, and Investment in Overall Survival John Policano The Future of Oncology Trials: Aligning Science, Regulation, and Investment in Overall Survival Read More »
The Next Precision Frontier: Scaling Beyond Oncology Dan Hennings The Next Precision Frontier: Scaling Beyond Oncology Read More »
In AI We Trust? The Shift from Calculator to Collaborator Dan Hennings In AI We Trust? The Shift from Calculator to Collaborator Read More »
Reclaiming the Impossible: Biotech Leaders on Breaking Through in Diseases the Industry Forgot Dan Hennings Reclaiming the Impossible: Biotech Leaders on Breaking Through in Diseases the Industry Forgot Read More »
Agentic AI in Clinical Trials: Accelerating Recruitment and Streamlining Operations for Large-Population Diseases Dan Hennings Agentic AI in Clinical Trials: Accelerating Recruitment and Streamlining Operations for Large-Population Diseases Read More »
Will Fungi Be the Last of Us? Reviving Infectious Disease Innovation Dan Hennings Will Fungi Be the Last of Us? Reviving Infectious Disease Innovation Read More »